Abdullah, Satra J.
HRN: 26-54-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
CEFUROXIME 500MG (TAB)
01/16/2025
01/23/2025
PO
500mg
BID X 7 Days
S/P NSVD; PROM X 31 Hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes